S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Opera Stock: The Fast-Rising Star of AI-Driven Web Experiences
15 A.I. Trading Opportunities a Day (Ad)
What Should Investors Make of These 3 Dividend Cuts?
Symbotic AI Robots Disrupt Warehouse Industry, Stock Price Soars
15 A.I. Trading Opportunities a Day (Ad)
CrowdStrike: Another Tech Stock to Buy on the Dip 
Broadcom Stock Pulls into the Buy Zone: Analysts Raise Targets
15 A.I. Trading Opportunities a Day (Ad)
Salesforce: Time to Snap it Up as the Market Buys the Dip?
Zscaler: Analysts Raise the Bar for the AI Cloud Security Company
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Opera Stock: The Fast-Rising Star of AI-Driven Web Experiences
15 A.I. Trading Opportunities a Day (Ad)
What Should Investors Make of These 3 Dividend Cuts?
Symbotic AI Robots Disrupt Warehouse Industry, Stock Price Soars
15 A.I. Trading Opportunities a Day (Ad)
CrowdStrike: Another Tech Stock to Buy on the Dip 
Broadcom Stock Pulls into the Buy Zone: Analysts Raise Targets
15 A.I. Trading Opportunities a Day (Ad)
Salesforce: Time to Snap it Up as the Market Buys the Dip?
Zscaler: Analysts Raise the Bar for the AI Cloud Security Company
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Opera Stock: The Fast-Rising Star of AI-Driven Web Experiences
15 A.I. Trading Opportunities a Day (Ad)
What Should Investors Make of These 3 Dividend Cuts?
Symbotic AI Robots Disrupt Warehouse Industry, Stock Price Soars
15 A.I. Trading Opportunities a Day (Ad)
CrowdStrike: Another Tech Stock to Buy on the Dip 
Broadcom Stock Pulls into the Buy Zone: Analysts Raise Targets
15 A.I. Trading Opportunities a Day (Ad)
Salesforce: Time to Snap it Up as the Market Buys the Dip?
Zscaler: Analysts Raise the Bar for the AI Cloud Security Company
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Opera Stock: The Fast-Rising Star of AI-Driven Web Experiences
15 A.I. Trading Opportunities a Day (Ad)
What Should Investors Make of These 3 Dividend Cuts?
Symbotic AI Robots Disrupt Warehouse Industry, Stock Price Soars
15 A.I. Trading Opportunities a Day (Ad)
CrowdStrike: Another Tech Stock to Buy on the Dip 
Broadcom Stock Pulls into the Buy Zone: Analysts Raise Targets
15 A.I. Trading Opportunities a Day (Ad)
Salesforce: Time to Snap it Up as the Market Buys the Dip?
Zscaler: Analysts Raise the Bar for the AI Cloud Security Company
NASDAQ:XXII

22nd Century Group (XXII) Stock Forecast, Price & News

$0.61
0.00 (0.00%)
(As of 06/2/2023 ET)
Compare
Today's Range
$0.60
$0.62
50-Day Range
$0.60
$0.79
52-Week Range
$0.58
$2.70
Volume
1.05 million shs
Average Volume
1.07 million shs
Market Capitalization
$135.21 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$4.00

22nd Century Group MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
558.2% Upside
$4.00 Price Target
Short Interest
Bearish
10.49% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.80mentions of 22nd Century Group in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.27) to ($0.08) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.66 out of 5 stars

Consumer Staples Sector

115th out of 140 stocks

Cigarettes Industry

5th out of 6 stocks


XXII stock logo

About 22nd Century Group (NASDAQ:XXII) Stock

22nd Century Group, Inc. is a biotechnology company, which engages in the business of tobacco harm reduction, reduced nicotine tobacco, and improvement of health and wellness through plant science. It operates through the Tobacco and Hemp/Cannabis segments. The Tobacco segment manufactures branded filtered cigars and cigarettes. The Hemp/Cannabis segment focuses on the bulk ingredient distillate or isolate. The company was founded on September 12, 2005 and is headquartered in Buffalo, NY.

Receive XXII Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for 22nd Century Group and its competitors with MarketBeat's FREE daily newsletter.

XXII Stock News Headlines

22nd Century Group (NASDAQ: XXII)
Free SMS Trade Alerts. Up to 15 opportunities a day.
Using our algorithm, we sift through 15,000 stocks every second. We generate 15 trading opportunities a day.
Free SMS Trade Alerts. Up to 15 opportunities a day.
Using our algorithm, we sift through 15,000 stocks every second. We generate 15 trading opportunities a day.
22nd Century Group enters agreement with Old Pal
See More Headlines

XXII Price History

XXII Company Calendar

Last Earnings
3/09/2023
Today
6/02/2023
Next Earnings (Estimated)
8/08/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Cigarettes
Sub-Industry
Cannabis
Current Symbol
NASDAQ:XXII
Employees
76
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$4.00
High Stock Price Forecast
$5.00
Low Stock Price Forecast
$3.00
Forecasted Upside/Downside
+558.2%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Net Income
$-59,800,000.00
Pretax Margin
-92.63%

Debt

Sales & Book Value

Annual Sales
$62.11 million
Book Value
$0.37 per share

Miscellaneous

Free Float
218,944,000
Market Cap
$135.21 million
Optionable
Optionable
Beta
1.80

Key Executives

  • James A MishJames A Mish
    President, Chief Executive Officer & Director
  • John J. Miller
    Chief Operating Officer & President-Tobacco
  • Robert Hugh Kinsman
    Chief Financial Officer
  • Juan Sanchez Tamburrino
    Vice President-Research & Development
  • Calvin Treat
    Chief Scientific Officer













XXII Stock - Frequently Asked Questions

Should I buy or sell 22nd Century Group stock right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for 22nd Century Group in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" XXII shares.
View XXII analyst ratings
or view top-rated stocks.

What is 22nd Century Group's stock price forecast for 2023?

2 brokers have issued 12-month price targets for 22nd Century Group's stock. Their XXII share price forecasts range from $3.00 to $5.00. On average, they expect the company's share price to reach $4.00 in the next year. This suggests a possible upside of 558.2% from the stock's current price.
View analysts price targets for XXII
or view top-rated stocks among Wall Street analysts.

How have XXII shares performed in 2023?

22nd Century Group's stock was trading at $0.9205 on January 1st, 2023. Since then, XXII stock has decreased by 34.0% and is now trading at $0.6077.
View the best growth stocks for 2023 here
.

When is 22nd Century Group's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 8th 2023.
View our XXII earnings forecast
.

How were 22nd Century Group's earnings last quarter?

22nd Century Group, Inc. (NASDAQ:XXII) issued its quarterly earnings results on Thursday, March, 9th. The biotechnology company reported ($0.12) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.06) by $0.06. The biotechnology company earned $19.21 million during the quarter, compared to analyst estimates of $19.26 million. 22nd Century Group had a negative net margin of 92.05% and a negative trailing twelve-month return on equity of 69.44%.

What ETFs hold 22nd Century Group's stock?

ETFs with the largest weight of 22nd Century Group (NASDAQ:XXII) stock in their portfolio include ETFMG Alternative Harvest ETF (MJ) and Invesco Nasdaq Future Gen 200 ETF (QQQS).

What guidance has 22nd Century Group issued on next quarter's earnings?

22nd Century Group issued an update on its FY 2023 earnings guidance on Tuesday, May, 9th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $105.00 million-$110.00 million, compared to the consensus revenue estimate of $96.11 million.

What other stocks do shareholders of 22nd Century Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other 22nd Century Group investors own include Aurora Cannabis (ACB), Alteryx (AYX), Auxly Cannabis Group (CBWTF), Charlotte's Web (CWBHF), Enphase Energy (ENPH), Inseego (INSG), Luckin Coffee (LKNCY), MediPharm Labs (MEDIF) and MercadoLibre (MELI).

What is 22nd Century Group's stock symbol?

22nd Century Group trades on the NASDAQ under the ticker symbol "XXII."

Who are 22nd Century Group's major shareholders?

22nd Century Group's stock is owned by a variety of retail and institutional investors. Top institutional investors include BlackRock Inc. (4.94%), Geode Capital Management LLC (1.61%), State Street Corp (1.32%), HighTower Advisors LLC (0.72%), ETF Managers Group LLC (0.56%) and Mirae Asset Global Investments Co. Ltd. (0.51%). Insiders that own company stock include Clifford B Fleet, James A Mish, John Franzino, Michael Zercher, Nora B Sullivan and Roger D O'brien.
View institutional ownership trends
.

How do I buy shares of 22nd Century Group?

Shares of XXII stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is 22nd Century Group's stock price today?

One share of XXII stock can currently be purchased for approximately $0.61.

How much money does 22nd Century Group make?

22nd Century Group (NASDAQ:XXII) has a market capitalization of $135.21 million and generates $62.11 million in revenue each year. The biotechnology company earns $-59,800,000.00 in net income (profit) each year or ($0.32) on an earnings per share basis.

How can I contact 22nd Century Group?

22nd Century Group's mailing address is 9530 Main St, CLARENCE, NY 14031-1915, United States. The official website for the company is www.xxiicentury.com. The biotechnology company can be reached via phone at (716) 270-1523, via email at investorrelations@xxiicentury.com, or via fax at 716-877-3064.

This page (NASDAQ:XXII) was last updated on 6/3/2023 by MarketBeat.com Staff

My Account -